Qing Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qing Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Chenxi Zhang
Capital Med Univ, Beijing Rehabil Hosp, Dept Pulm & Crit Care Med, Badachu Rd, Beijing 100144, Peoples R China
2 shared publications - Hongying Jiang
Department of Pulmonary and Critical Care Medicine, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China
2 shared publications - Jianing Xi
Department of Rehabilitation, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China
2 shared publications - Yi Li
Department of Respiratory Rehabilitation Center, Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China
2 shared publications - Zhanqi Zhao
School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, China
2 shared publications - Feng Fu
Department of Biomedical Engineering, The Fourth Military Medical University, Xi’an 710032, China
1 shared publication
Latest Publications
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA3581
Evaluating the effects of intermittent oro-esophageal in tracheotomy patients with neurogenic dysphagia: a randomized study
Objective: To explore the effects of IOE on decannulation and nutritional status in patients with neurogenic dysphagia and tracheotomy. Methods: This randomized controlled trial enrolled tracheotomized patients with neurogenic dysphagia admitted to three hospitals between January–December 2025. The IOE group or control group. Relevant data were collected, including decannulation time, decannulation rate within 1 month, penetration-aspiration scale (PAS) grades, nutritional parameters (albumin, prealbumin, total protein, BMI), and swallowing-related quality of life. Results: A total of 140 patients were included (IOE group: 70; control group: 70). Compared with the control group, the IOE group had a significantly shorter decannulation time (18.07±6.93 vs. 22.21±5.90 days, P < 0.05) and higher decannulation rate (65.71% vs. 47.14%, P < 0.05). At 2 weeks, the IOE group showed better PAS grades and swallowing-related quality of life (5.50±2.39 vs. 7.40±1.62, 170.31±18.32 vs. 124.36±20.92, P < 0.001). BMI in the IOE group increased more but showed no difference at 2 weeks (P > 0.05) while being significantly higher at 1 month (22.73±2.58 vs. 21.73±2.93, P < 0.05). Nutritionally, the IOE group had superior albumin, prealbumin, and total protein at 2 weeks (36.56±3.45 vs. 35.37±3.51 g/L; 0.23±0.13 vs. 0.19±0.07 g/L; 69.21±6.25 vs. 66.49±6.50 g/L, all P < 0.05) and more pronounced improvements at 1 month (37.93±4.20 vs. 36.16±5.49 g/L; 0.23±0.12 vs. 0.19±0.08 g/L; 70.62±7.05 vs. 68.14±6.91 g/L, all P < 0.01). Conclusion: IOE effectively shortens decannulation time, increases decannulation rate, and improves nutritional status in patients with neurogenic dysphagia and tracheotomy, serving as a valuable clinical intervention.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA3581
Evaluating the effects of intermittent oro-esophageal in tracheotomy patients with neurogenic dysphagia: a randomized study
Objective: To explore the effects of IOE on decannulation and nutritional status in patients with neurogenic dysphagia and tracheotomy. Methods: This randomized controlled trial enrolled tracheotomized patients with neurogenic dysphagia admitted to three hospitals between January–December 2025. The IOE group or control group. Relevant data were collected, including decannulation time, decannulation rate within 1 month, penetration-aspiration scale (PAS) grades, nutritional parameters (albumin, prealbumin, total protein, BMI), and swallowing-related quality of life. Results: A total of 140 patients were included (IOE group: 70; control group: 70). Compared with the control group, the IOE group had a significantly shorter decannulation time (18.07±6.93 vs. 22.21±5.90 days, P < 0.05) and higher decannulation rate (65.71% vs. 47.14%, P < 0.05). At 2 weeks, the IOE group showed better PAS grades and swallowing-related quality of life (5.50±2.39 vs. 7.40±1.62, 170.31±18.32 vs. 124.36±20.92, P < 0.001). BMI in the IOE group increased more but showed no difference at 2 weeks (P > 0.05) while being significantly higher at 1 month (22.73±2.58 vs. 21.73±2.93, P < 0.05). Nutritionally, the IOE group had superior albumin, prealbumin, and total protein at 2 weeks (36.56±3.45 vs. 35.37±3.51 g/L; 0.23±0.13 vs. 0.19±0.07 g/L; 69.21±6.25 vs. 66.49±6.50 g/L, all P < 0.05) and more pronounced improvements at 1 month (37.93±4.20 vs. 36.16±5.49 g/L; 0.23±0.12 vs. 0.19±0.08 g/L; 70.62±7.05 vs. 68.14±6.91 g/L, all P < 0.01). Conclusion: IOE effectively shortens decannulation time, increases decannulation rate, and improves nutritional status in patients with neurogenic dysphagia and tracheotomy, serving as a valuable clinical intervention.
- 31 January 2022
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 299, 103854
Regional ventilation distribution in patients with scoliosis assessed by electrical impedance tomography: Is individual thorax shape required?
- 31 January 2022
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 299, 103854
Regional ventilation distribution in patients with scoliosis assessed by electrical impedance tomography: Is individual thorax shape required?
- 1 October 2021
- Published by IOP Publishing in Physiological Measurement
- Vol. 42 (10) , 104001
Ventilation improvement after pneumonia treatment evaluated with electrical impedance tomography: an observational study
Objective. Due to radiation exposure, not all patients with pneumonia receive chest x-rays or CT measurements to confirm treatment effectiveness. The aim of this study was to examine the ability to use electrical impedance tomography (EIT) to evaluate the treatment effectiveness in such patient group. Approach . A total of 35 consecutive patients with non-severe pneumonia were included in this prospective study. The patients received standard treatment according to our internal protocol. EIT measurements were performed in supine position before the treatment started and on day 6 of the treatment period. The EIT-based global inhomogeneity ( GI ) index and center of ventilation ( CoV ) index were calculated. The clinical pulmonary infection score (CPIS) was obtained at both time points. Main r esults. Clinically significant improvements in GI and CoV were found in the patient group (Δ GI : −34% ± 17% and Δ CoV : −10% ± 11%; p CPIS −0.70 ± 0.17, p GI or Δ CoV. Significance. EIT demonstrated individual improvement of ventilation heterogeneity after standard treatment in non-severe pneumonia, and provided different information compared to CPIS. EIT has the potential to become a routine non-invasive, non-radiative tool to assess pneumonia treatment effectiveness.
- 1 October 2021
- Published by IOP Publishing in Physiological Measurement
- Vol. 42 (10) , 104001
Ventilation improvement after pneumonia treatment evaluated with electrical impedance tomography: an observational study
Objective. Due to radiation exposure, not all patients with pneumonia receive chest x-rays or CT measurements to confirm treatment effectiveness. The aim of this study was to examine the ability to use electrical impedance tomography (EIT) to evaluate the treatment effectiveness in such patient group. Approach . A total of 35 consecutive patients with non-severe pneumonia were included in this prospective study. The patients received standard treatment according to our internal protocol. EIT measurements were performed in supine position before the treatment started and on day 6 of the treatment period. The EIT-based global inhomogeneity ( GI ) index and center of ventilation ( CoV ) index were calculated. The clinical pulmonary infection score (CPIS) was obtained at both time points. Main r esults. Clinically significant improvements in GI and CoV were found in the patient group (Δ GI : −34% ± 17% and Δ CoV : −10% ± 11%; p CPIS −0.70 ± 0.17, p GI or Δ CoV. Significance. EIT demonstrated individual improvement of ventilation heterogeneity after standard treatment in non-severe pneumonia, and provided different information compared to CPIS. EIT has the potential to become a routine non-invasive, non-radiative tool to assess pneumonia treatment effectiveness.